Beyond typing and grading: target analysis in individualized therapy as a new challenge for tumour pathology

Area of Science:

• Oncology
• Pathology
• Biomarker Analysis

Background:

• Targeted therapy efficacy in oncology relies on precise target identification in tumors.
• Immunohistochemistry and molecular methods are standard for detecting therapeutic targets in cancer tissue.
• Histopathological analysis requires robust quality assurance for reliable and reproducible results.

Purpose of the Study:

• To establish an external quality assurance model for tissue-based target analysis in targeted cancer therapy.
• To assess the reliability and reproducibility of biomarker expression testing across laboratories.

Main Methods:

• An annual inter-laboratory trial was conducted in Germany.
• Tissue arrays comprising up to 60 breast cancer samples were utilized.
• Participants tested samples for the expression of HER2/neu and steroid hormone receptors.

Main Results:

• The study established a framework for external quality assurance in targeted therapy biomarker testing.
• The inter-laboratory trial provided data on the performance of participants in assessing key breast cancer biomarkers.
• This model facilitates the evaluation of diagnostic accuracy in histopathology for targeted treatments.

Conclusions:

• External quality assurance programs are essential for ensuring the accuracy of tissue-based target analysis in oncology.
• The implemented trial serves as a model for quality control in biomarker detection for targeted therapies.
• Consistent and reliable biomarker assessment is critical for optimizing patient outcomes in targeted cancer treatment.